NCT07859540Not yet recruiting
Negotiation Training for Family Caregivers of People With Alzheimer's Disease
Negotiation Training to Optimize Caregiver Communication in Alzheimer's Disease
Source: ClinicalTrials.gov · Last updated 28 Oct 2026
Brief summary (registry, in English)
Family caregivers of people living with Alzheimer's disease and related dementias often experience conflicts and communication challenges when coordinating care, making decisions, and interacting with family members and healthcare providers. These challenges can contribute to caregiver burden, stress, anxiety, and reduced well-being. The purpose of this study is to evaluate the effectiveness of NegotiAge, an online negotiation and communication training program designed for family caregivers. NegotiAge provides education and interactive practice exercises to help caregivers develop negotiation, problem-solving, conflict-resolution, and communication skills that can be applied to real-world caregiving situations. Approximately 200 family caregivers will be randomly assigned to either the NegotiAge intervention or an attention-control educational website. Participants will complete online surveys before the intervention, immediately after the intervention, and at 1-month and 3-month follow-up time-points. The study will examine whether NegotiAge reduces caregiver burden and improves communication, conflict-management behaviors, self-efficacy, stress, anxiety, fatigue, and well-being. Findings from this research may help improve support programs for family caregivers of people living with Alzheimer's disease and related dementias.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 29 Sept 2026
- Start date
- Dec 2026
- Primary completion date
- Apr 2028
- Lead sponsor
- Northwestern University
- Diseases
- Alzheimer disease
- NCT number
- NCT07859540
What you commit to
- Study type: Interventional
- Planned participants: 200
- From Dec 2026 to the primary completion date, Apr 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior participation in PlanYourLifespan studies (STU00209195 or STU00225351).
- Prior participation in any NegotiAge study (STU00212921).
Other illness
- Not currently serving as a family caregiver or unpaid care partner for a person with Alzheimer's disease, a related dementia, cognitive impairment, or memory loss.
- Significant cognitive impairment or another condition that would prevent meaningful participation in study activities.
Age
- Younger than 21 years of age.
Other
- Unable to provide informed consent.
- Unable to read, understand, or communicate in English sufficiently to complete study activities.
- Lack of access to the technology required for participation in the online intervention and study assessments.
Who the study is looking for
- Age 21 years or older
- Self-identify as a family caregiver or unpaid care partner of a person with Alzheimer's disease, a related dementia, cognitive impairment, or memory loss.
- Provide at least 2 hours per week of assistance, support, advocacy, healthcare coordination, or decision-making for the care recipient.
- Able to read, understand, and communicate in English.
- Able and willing to provide informed consent.
- Have regular access to an internet-connected computer, tablet, or smartphone and be comfortable using web-based programs and surveys.
- Willing to be randomized to either the NegotiAge intervention group or the attention-control group and complete all study assessments.
Age in the registry: 21 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Northwestern University Feinberg School of Medicine Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.